Pull to refresh
Logo
Stanford Medicine

Stanford Medicine

Academic medical research institution

Appears in 6 stories

Stories

AI agent team designs a lung-cancer drug in Stanford's virtual biotech

New Capabilities

Developed and operates the Virtual Biotech platform

Stanford built a drug-discovery operation with 37,000 AI agents and no lab benches. The virtual biotech analyzed 55,984 clinical trials and proposed a lung-cancer therapy that a human pharmaceutical company matched months later.

Updated Yesterday

Study finds human brain grows from two separate cell lineages

New Capabilities

Lead institution behind the research

Scientists grew functional human hindbrain motor neurons in a lab dish after discovering the brain develops from two separate groups of progenitor cells, not one. The Stanford Medicine-led team reported the finding Sept. 18 in Nature Neuroscience.

Updated Sep 23

Stanford's Gerozyme breakthrough: regrowing cartilage without stem cells

New Capabilities

Research institution behind the discovery

A November 2025 study in Science showed that blocking an enzyme called 15-PGDH regrew cartilage in older mice and in human joint tissue from knee replacement patients. Blocking it shifts cartilage cells from degrading to rebuilding—without stem cells.

Updated Jun 13

The race to restore sight

New Capabilities

Developed PRIMA technology, co-led clinical trials

Stanford researchers implanted a chip smaller than a Tic Tac under the retinas of 38 blind patients. A year later, 27 could read again, including some who read entire books. The PRIMA device, published October 20, 2025 in the New England Journal of Medicine, is the first prosthetic to restore functional vision to people with macular degeneration—the leading cause of irreversible blindness.

Updated May 19

The vaccine that might prevent dementia

New Capabilities

Investigating vaccine effects on dementia progression

A shingles vaccine is showing up in dataset after dataset as a dementia preventer. Oxford researchers published results in Nature Medicine in July 2024, showing Shingrix (the recombinant shingles vaccine) cuts dementia risk by 17-20% compared to unvaccinated people.

Updated May 19

AI cracks the sleep code: one night predicts 130 diseases

New Capabilities

Leading AI medical research institution

Stanford researchers trained an AI on 600,000 hours of people sleeping. SleepFM analyzes brain waves, heartbeats, and breathing from a single night and predicts your risk for 130 diseases—dementia, heart attacks, cancer, mental disorders—with over 80% accuracy. The breakthrough turns a night of sleep into a comprehensive disease-screening tool.

Updated May 19